Related Announcements

RFA-CA-21-045 - Coordinating Center for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network (U24 Clinical Trial Required)

RFA-CA-21-046 - Research Bases for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network (UG1 Clinical Trial Required)

RFA-CA-21-047 - Clinical Sites for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network (UG1 Clinical Trial Required)

Issued by

National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to inform the research community about the availability of the recording of the Technical Assistance Webinar and subsequent Frequently Asked Questions (FAQs) that were held on November 9, 2021 for the three (RFA-CA-21-045, RFA-CA-21-046, RFA-CA-21-047) HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network Funding Opportunity Announcements (FOAs), which were issued by the National Cancer Institute (NCI) On October 26, 2021.

To access the webinar recording and FAQs, please visit the NCI's HIV/Cervical Cancer Prevention ‘CASCADE’ Clinical Trials Network website.

Inquiries

Please direct all inquiries to:

Vikrant V. Sahasrabuddhe, M.B.B.S., Dr.P.H.
National Cancer Institute (NCI)
Telephone: 240-276-7332
Email: [email protected]
[email protected]